Hepatitis B Stocks List

Recent Signals

Date Stock Signal Type
2021-03-08 ABUS 180 Bearish Setup Bearish Swing Setup
2021-03-08 ABUS Slingshot Bearish Bearish Swing Setup
2021-03-08 ABUS Fell Below 200 DMA Bearish
2021-03-08 AIM 180 Bearish Setup Bearish Swing Setup
2021-03-08 ALGS Stochastic Buy Signal Bullish
2021-03-08 ALGS Slingshot Bearish Bearish Swing Setup
2021-03-08 ARWR Lower Bollinger Band Walk Weakness
2021-03-08 ARWR Slingshot Bearish Bearish Swing Setup
2021-03-08 ARWR 180 Bearish Setup Bearish Swing Setup
2021-03-08 ARWR Stochastic Buy Signal Bullish
2021-03-08 BMY 20 DMA Resistance Bearish
2021-03-08 BMY 200 DMA Resistance Bearish
2021-03-08 BMY 180 Bearish Setup Bearish Swing Setup
2021-03-08 BNTC NR7 Range Contraction
2021-03-08 BNTC Narrow Range Bar Range Contraction
2021-03-08 CBPO Stochastic Reached Oversold Weakness
2021-03-08 GOVX 50 DMA Resistance Bearish
2021-03-08 GOVX Stochastic Buy Signal Bullish
2021-03-08 GOVX New Uptrend Bullish
2021-03-08 HEPA Spinning Top Other
2021-03-08 HEPA Bullish Engulfing Bullish
2021-03-08 HOOK Spinning Top Other
2021-03-08 HOOK 20 DMA Support Bullish
2021-03-08 HOOK Pocket Pivot Bullish Swing Setup
2021-03-08 HOOK Bollinger Band Squeeze Range Contraction
2021-03-08 INO 180 Bearish Setup Bearish Swing Setup
2021-03-08 INO NR7 Range Contraction
2021-03-08 INO Narrow Range Bar Range Contraction
2021-03-08 INO Lower Bollinger Band Walk Weakness
2021-03-08 IONS Slingshot Bearish Bearish Swing Setup
2021-03-08 IONS 180 Bearish Setup Bearish Swing Setup
2021-03-08 NNVC 200 DMA Support Bullish
2021-03-08 NNVC MACD Bearish Signal Line Cross Bearish
2021-03-08 NNVC Calm After Storm Range Contraction
2021-03-08 NNVC Fell Below 20 DMA Bearish
2021-03-08 NTLA Lower Bollinger Band Walk Weakness
2021-03-08 NTLA Stochastic Buy Signal Bullish
2021-03-08 SBTX 20 DMA Resistance Bearish
2021-03-08 SBTX Crossed Above 50 DMA Bullish
2021-03-08 SBTX Expansion Pivot Buy Setup Bullish Swing Setup
2021-03-08 VIR Narrow Range Bar Range Contraction
2021-03-08 VIR Calm After Storm Range Contraction
2021-03-08 VIR NR7 Range Contraction
2021-03-08 VIR 180 Bearish Setup Bearish Swing Setup
2021-03-08 VIR Lower Bollinger Band Walk Weakness

Recent News for Hepatitis B Stocks

Date Stock Title
Mar 8 BMY Bristol-Myers Squibb Contingent Value Rights: Thinking Through The Options Around Litigation Financing
Mar 8 BMY NIH starts trial enrollment for Bristol/Pfizer's Eliquis for blood clots in COVID patients
Mar 8 AIM AIM Immunotech starts dosing in early-stage intranasal ampligen study
Mar 8 CODX Co-Diagnostics to Discuss Recent Company Advances at H.C. Wainwright Global Life Sciences Virtual Conference
Mar 8 AIM AIM ImmunoTech Announces First Healthy Subjects Dosed in Phase 1 Intranasal Ampligen Clinical Study
Mar 8 IONS TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors
Mar 8 ALGS Aligos Therapeutics Presents Nonclinical Data for its COVID-19 Therapeutic in Development at the 2021 Conference on Retroviruses and Opportunistic Infections
Mar 8 SBTX Silverback Therapeutics (SBTX) Investor Presentation - Slideshow
Mar 8 SVA Philippines, Moderna Reach 13M Vaccine Doses Supply Pact
Mar 8 VIR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vir Biotechnology, Inc. - VIR
Mar 7 NTLA Intellia Therapeutics Is At A Pivotal Moment
Mar 6 BMY Why Is Bristol Myers (BMY) Down 1.8% Since Last Earnings Report?
Mar 6 VXRT Is Short-Selling a Risk for Moderna?
Mar 6 VXRT Where Will Vaxart Be in 1 Year?
Mar 6 VXRT Should You Buy Vaxart Stock in March?
Mar 5 VXRT Bireme Capital: “Vaxart, Inc. is Exhibiting Classic Pretender Signals”
Mar 5 VIR Vir Biotechnology and GlaxoSmithKline Expand Their COVID Partnership to Flu
Mar 5 VIR NIH stops clinical trials for two experimental antibody COVID-19 treatments
Mar 5 VXRT Can This 1 Element Keep Vaxart in the Coronavirus Vaccine Race?
Mar 5 SVA Sinovac vaccine may not trigger sufficient antibody response to Brazil variant -study

Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, tiredness, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications result in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. The diagnosis is usually confirmed by testing the blood for parts of the virus and for antibodies against the virus. It is one of five main hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease, antiviral medication such as tenofovir or interferon may be useful; however, these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 343 million who have chronic infections. Another 129 million new infections occurred in 2013. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults are chronically infected. Rates in Europe and North America are less than 1%. It was originally known as "serum hepatitis". Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.

More about Hepatitis B
Browse All Tags